Urinary marker panels for aggressive prostate cancer detection

Majority of patients with indolent prostate cancer (PCa) can be managed with active surveillance. Therefore, finding biomarkers for classifying patients between indolent and aggressive PCa is essential. In this study, we investigated urinary marker panels composed of urinary glycopeptides and/or uri...

Descripción completa

Detalles Bibliográficos
Autores principales: Lih, Tung-Shing Mamie, Dong, Mingming, Mangold, Leslie, Partin, Alan, Zhang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437030/
https://www.ncbi.nlm.nih.gov/pubmed/36050450
http://dx.doi.org/10.1038/s41598-022-19134-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437030/
https://www.ncbi.nlm.nih.gov/pubmed/36050450
http://dx.doi.org/10.1038/s41598-022-19134-3

Ejemplares similares